Common Partnership Types
Biopharmaceutical
For our biopharma partners, Ambry streamlines the therapeutic development process by providing robust analytical and clinical validation . Leveraging a consented real-world database from over 2.5 million genetic tests, we deliver the deeper insights necessary to inform and advance precision medicine.
Academia and Research
Ambry accelerates scientific discovery through 100+ active collaborations with top-tier academic institutions, public repositories, and a longstanding commitment to data sharing. Together, we translate vast genomic datasets into peer-reviewed discoveries that collectively advance the field.
Clinical Teams and Health Systems
The award-winning Ambry CARE program integrates digital health applications into clinical workflows to identify high-risk patients and standardize care. This end-to-end platform streamlines genetic testing and makes result reports, patient educational materials, and post-test genetic counseling accessible in one place.
AmbryLink: No-Cost Testing Programs
AmbryLink is a sponsored testing program available at no cost. It enables biopharmaceutical partners to identify rare disease patients more quickly and accurately, shortening the diagnostic journey for patients. The program maximizes patient identification by bringing together Ambry’s genetic testing, an established network of relationships at major academic centers, and broad field support to lower access barriers.